Skip to main content
Livermore
Livermore
ZHEN

Wealthspire Advisors, LLC

SEC CIK
0001646247
Latest filing
Aug 11, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Wealthspire Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
18,142
Value
$570.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CPRX by Wealthspire Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,142$570.2K<0.1%−16,217−47.2%ReducedHolders
Q1 202634,359$850.7K<0.1%−2,801−7.5%ReducedHolders
Q4 202537,160$867.3K<0.1%+317+0.9%AddedHolders
Q3 202536,843$725.8K<0.1%−36−0.1%ReducedHolders
Q2 202536,879$800.3K<0.1%+2,445+7.1%AddedHolders
Q1 202534,434$835.0K<0.1%+79+0.2%AddedHolders
Q4 202434,355$717.0K<0.1%+84+0.2%AddedHolders
Q3 202434,271$681.3K<0.1%−2,021−5.6%ReducedHolders
Q2 202436,292$562.2K<0.1%00.0%UnchangedHolders
Q1 202436,292$578.5K<0.1%00.0%UnchangedHolders
Q4 202336,292$610.1K<0.1%00.0%UnchangedHolders
Q3 202336,292$424.3K<0.1%−2,978−7.6%ReducedHolders
Q2 202339,270$527.8K<0.1%00.0%UnchangedHolders
Q1 202339,270$651.1K<0.1%+4,614+13.3%AddedHolders
Q4 202234,656$644.6K<0.1%+386+1.1%AddedHolders
Q3 202234,270$440.0K<0.1%−48,500−58.6%ReducedHolders
Q2 202282,770$580.0K<0.1%00.0%UnchangedHolders
Q1 202282,770$686.0K<0.1%−55,000−39.9%ReducedHolders
Q4 2021137,770$933.0K<0.1%−200,000−59.2%ReducedHolders
Q3 2021337,770$1.79M<0.1%00.0%UnchangedHolders
Q2 2021337,770$1.94M0.1%00.0%UnchangedHolders
Q1 2021337,770$1.56M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.